Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proteomics and metabolomics in inflammatory bowel disease.

Journal of gastroenterology and hepatology - 1 Jul 2013

Yau Yunki, Leong Rupert W, Zeng Ming, Wasinger Valerie C

Abstract excerpt

Genome-wide studies in inflammatory bowel disease (IBD) have allowed us to understand Crohn's disease and ulcerative colitis as forms of related autoinflammatory disorders that arise from a multitude of pathogenic origins. Proteomics and metabolomics are the offspring of genomics that possess unprecedented possibilities to characterize unknown pathogenic pathways. It has been about a decade since proteomics was...

Topics

Join the communities discussing this publication.

Environmental Exposure
Genome-Wide Association Study
High-Throughput Screening Assays
Inflammatory Bowel Diseases
Metabolome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23489082
DOI: 10.1111/jgh.12193

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proteomics and metabolomics in inflammatory bowel disease.PMID 23489082Read ↗

Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future PerspectivesSemantic proximity Read ↗

Multi-omics in Crohn's disease: New insights from insideSemantic proximity Read ↗

Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.Semantic proximity Read ↗

Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn’s DiseaseSemantic proximity Read ↗

Multi-omics phenotyping characterizes molecular divergence underlying different clinical scenarios of inflammatory bowel diseaseSemantic proximity Read ↗

Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine.Semantic proximity Read ↗

Identifying robust biomarkers for the diagnosis and subtype distinction of inflammatory bowel disease through comprehensive serum metabolomic profilingSemantic proximity Read ↗

Genomics and proteomics: implications for inflammatory bowel diseases.Semantic proximity Read ↗

IBD metabonomics predicts phenotype, disease course, and treatment response.Semantic proximity Read ↗

The Role of Host Genetics, Intestinal Microbiota and Metabolome as a New Insight into IBD PathogenesisSemantic proximity Read ↗

The Role of Host Genetics and Intestinal Microbiota and Metabolome as a New Insight into IBD PathogenesisSemantic proximity Read ↗

Etiopathogenesis of inflammatory bowel disease: today and tomorrow.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.